New England journal endorses institute's proposals for FDABMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7572.772 (Published 12 October 2006) Cite this as: BMJ 2006;333:772
- Janice Tanne
- New York
The United States faces a “mounting public health crisis in drug safety, and definitive action must be taken” to revitalise the Food and Drug Administration, said Jeffrey Drazen, editor of the New England Journal of Medicine in an editorial that was also signed by two of the journal's senior editors.
The FDA has been politicised, and “this trend must be stopped,” says the editorial, which was published online on 9 October (http://www.nejm.org/, doi:10.1056/NEJMe068237). The FDA's decisions about the nation's drug supply “should be based solely on scientific evidence.”
The FDA has “critical issues of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial